SPHK1 and cancer: Xia and colleagues first identified the oncogenic potential of SphK1 in 2000 [221], and evidence supporting a key role in neoplastic survival and growth has come from SphK1−/− mouse models showing reduced tumor size [222] and increased expression of hSphK1 has been reported in many different cancer types (Table 1) [97, 223].